Institutional investors purchased a net $584.0 thousand shares of GHDX during the quarter ended September 2016, and now own 90.65% of the total float, a percentage that is typical for companies in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
COLUMBIA WANGER ASSET MANAGEMENT... Bought 468.6 Thousand shares of Genomic Health Inc
EAGLE ASSET MANAGEMENT, INC. Bought 291.1 Thousand shares of Genomic Health Inc
CHARLES SCHWAB INVESTMENT MANAGE... Bought 245.3 Thousand shares of Genomic Health Inc